Pharmafile Logo

Virtual workshop

Mobile app for conference highlights

Doctors.net.uk has launched a mobile phone app providing members with details of the latest medical conferences via their smartphone

- PMLiVE

The formation of the NHS

Exploring the industry's most important dates, we recall July 1948: the formation of the NHS in the UK

- PMLiVE

PMGroup launches New Health Strategies

PMGroup has announced the launch of New Health Strategies – a series of digital publications analysing key issues in healthcare policy, commencing with 'commissioning groups' within the NHS in England

UK diabetes risk levels rise

Over 800,000 people with diabetes in the UK are at risk of complications related to the condition due to high blood sugar levels according the National Diabetes Audit 2009-10

- PMLiVE

Interview: Richard Bergström, EFPIA

The new director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA) tells Liz Wells about the challenges involved in keeping the regional market sustainable 

NICE recommends RA drug

The UK's National Institute for Health and Clinical Excellence has issued final guidance recommending Centocor Ortho Biotech's rheumatoid arthritis drug Simponi in specific, limited circumstances

NICE to retain powers

As part of changes announced to the UK government's Health and Social Care Bill, the National Institute of Health and Clinical Excellence is to retain its responsibility to recommend drugs...

David Cameron overhauls NHS reforms

UK Prime Minister David Cameron has announced significant changes to the NHS Health and Social Care Bill following criticism received as the result of an independent review

UK launches stem cell centre

King's College London is to set up a centre for stem cell and regenerative medicine

Drive for more UK clinical trials

The NHS Confederation has called for a halt in the decline of UK-based clinical trials, describing efforts to increase the number as 'hampered' by the EU

NICE recommends Allergan eye implant

Allergan’s Ozurdex eye implant to treat macular oedema has been approved for use by the UK’s NHS in draft guidance from the National Institute for Health and Clinical Excellence

Servier defends Perindopil overcharging claim

Servier refutes claims made by the UK's Department of Health the company is overcharging for high blood pressure and heart disease drug Perindopil

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links